Biochemical Reagent
-
BA6772 PYD-106Summary: PYD-106 is a stereoselective pyrrolidone (PYD) orthosteric modulator for GluN2C-containing NMDA receptors. - BA6773 PF-4778574Summary: PF-4778574 is an orthosteric modulation of the receptor.
- BA6774 UK-240455Summary: An effective and selective antagonist at the N-methyl D-aspartate glycine site.
- BA6775 ValbenazineSummary: Valbenazine (NBI-98854) is a vesicular monoamine transporter 2 inhibitor.
- BA6776 NBI-98782Summary: NBI-98782 is a high-affinity and selective inhibitor of vesicular monoamine transporter protein 2.
- BA6777 NisoxetineSummary: Nisoxetine is a potent and selective inhibitor of norepinephrine transporter protein.
- BA6778 hENT4-IN-1Summary: hENT4-IN-1 is a potent and selective inhibitor of human-derived (equilibrative nucleoside transporter 4).
- BA6779 GZ-793ASummary: GZ-793A is an orally active and selective inhibitor of vesicular monoamine transporter-2.
- BA6780 LiafensineSummary: Liafensine (BMS-820836) is a triple monoamine reuptake inhibitor that inhibits the dopamine transporter, serotonin transporter, and norepinephrine transporter.
- BA6781 SyrosingopineSummary: Syrosingopine (Su3118) is an orally potent dual inhibitor of lactate transporter proteins that reduces glycolysis and induces synthetic lethality in cancer cells when combined with metformin.